Larvol Delta - Arch-Biopartners-Expands-Dosing-in-Phase-I-Trial-for-Metablok-to-Increase-Dose-Range-for-Future-Phase-II-Studies

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2020/03/04/1995191/0/en/Arch-Biopartners-Expands-Dosing-in-Phase-I-Trial-for-Metablok-to-Increase-Dose-Range-for-Future-Phase-II-Studies.html

Mar 4, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next